EKF Diagnostics (LON:EKF) Stock Price Crosses Above 200-Day Moving Average - Time to Sell?

EKF Diagnostics Holdings plc (LON:EKF - Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 23.88 ($0.32) and traded as high as GBX 27 ($0.36). EKF Diagnostics shares last traded at GBX 27 ($0.36), with a volume of 58,942 shares trading hands.

EKF Diagnostics Stock Up 1.8%

The stock has a market cap of £114.67 million, a P/E ratio of 24.01 and a beta of 0.57. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.77 and a current ratio of 4.60. The firm's 50-day moving average is GBX 22.20 and its two-hundred day moving average is GBX 23.81.

EKF Diagnostics (LON:EKF - Get Free Report) last issued its earnings results on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a return on equity of 7.03% and a net margin of 9.37%. On average, equities research analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 earnings per share for the current year.

Insider Transactions at EKF Diagnostics

In other EKF Diagnostics news, insider Gavin T. Jones bought 50,000 shares of EKF Diagnostics stock in a transaction on Tuesday, March 25th. The shares were purchased at an average cost of GBX 22 ($0.30) per share, with a total value of £11,000 ($14,864.86). 5.24% of the stock is currently owned by insiders.

About EKF Diagnostics

EKF is an AIM-listed global diagnostics business focussed on: ● Point-of-Care analysers in the key areas of Hematology and Diabetes ● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications. EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.